BEUDAMED
    5,947 results · 46ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

    Sivantos GmbH

    FDA registration
    Sivantos GmbH·1 product·🇩🇪 Germany

    Ambu PEEP 20 Valve

    FDA registration
    AMBU Limited·1 product·🇨🇳 China

    Concentric Needle Electrode

    FDA registration
    AMBU SDN.BHD.·1 product·🇲🇾 Malaysia

    GSI Novus

    FDA registration
    DGS Diagnostics Sp. z o.o·2 products·🇵🇱 Poland

    AA222

    FDA registration
    DGS Diagnostics Sp. z o.o·1 product·🇵🇱 Poland

    REM440

    FDA registration
    DGS Diagnostics Sp. z o.o·1 product·🇵🇱 Poland

    Range+QUALICHECK LEVEL 1,2,3

    FDA registration
    Radiometer Solutions Sp. z o.o.·1 product·🇵🇱 Poland

    ABL90 FLEX

    FDA registration
    Radiometer Solutions Sp. z o.o.·12 products·🇵🇱 Poland

    Ambu® aBox™ 2

    FDA registration
    AMBU SDN.BHD.·1 product·🇲🇾 Malaysia

    Ponto 5 SuperPower

    FDA registration
    Demant Operations Poland Sp. z o.o.·2 products·🇵🇱 Poland

    TCM40 Monitoring System,

    FDA registration
    Radiometer Solutions Sp. z o.o.·4 products·🇵🇱 Poland

    Dorsal Root Ganglion Stimulator For Pain Relief

    FDA Pre-Market Approval
    FDA Class 3 ·St. Jude Medical Clinician Programmer Application, St. Jude Medical Patient Controller Application, Proclaim DRG Implant

    INVACARE® BARIATRIC BED RAIL

    FDA UDI
    INVACARE CORPORATION·00841447102656·

    INVACARE® BARIATRIC BED RAIL

    FDA UDI
    INVACARE CORPORATION·00841447100720·

    Perflex Thermofix

    FDA UDI
    PERFLEX LTD·07290110501938·Thermoplastic pellets softens with a dip hot wa...

    Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    FDA Pre-Market Approval
    FDA Class 3 ·HER2 CISH PHARMDX KIT

    Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    FDA Pre-Market Approval
    FDA Class 3 ·HER2 CISH PHARMDX KIT

    Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    FDA Pre-Market Approval
    FDA Class 3 ·HER2 CISH PHARMDX KIT

    Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    FDA Pre-Market Approval
    FDA Class 3 ·HER2 CISH PHARMDX KIT

    Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer

    FDA Pre-Market Approval
    FDA Class 3 ·HER2 CISH PHARMADX KIT